Vitamin K2 Market To Expand at 12.3% CAGR by 2034

Overview

New York, NY – June 25, 2025 – The Global Vitamin K2 Market is projected to soar from USD 212.6 Million in 2024 to an impressive USD 678.2 Million by 2034, achieving a strong CAGR of 12.3% during the forecast period from 2025 to 2034.

In 2024, MK-7 led the global Vitamin K2 market with a 68.9% share, driven by its superior bioavailability, extended plasma half-life of up to 72 hours, and growing consumer preference for daily supplements. Capsules and tablets commanded a 47.1% share of the global Vitamin K2 market in 2024, valued for their convenience, precise dosing, long shelf life, and widespread consumer acceptance.

Natural Vitamin K2, primarily MK-7 from Bacillus subtilis natto fermentation, held a 67.4% market share in 2024. Its popularity stems from demand for clean-label, plant-based, and minimally processed supplements. Bone Health dominated the Vitamin K2 market in 2024 with a 51.3% share, fueled by rising awareness of age-related bone loss, particularly among postmenopausal women and seniors.

Key Takeaways

• Vitamin K2 Market size is expected to be worth around USD 678.2 Million by 2034, from USD 212.6 Million in 2024, growing at a CAGR of 12.3%.
• MK-7 held a dominant market position, capturing more than a 68.9% share of the global Vitamin K2 market.
• Capsules and tablets held a dominant market position, capturing more than a 47.1% share of the global Vitamin K2 market.
• Natural held a dominant market position, capturing more than a 67.4% share of the global Vitamin K2 market.
• Bone Health held a dominant market position, capturing more than a 51.3% share of the global Vitamin K2 market.
• Health Supplements held a dominant market position, capturing more than a 77.7% share of the global Vitamin K2 market.
• Offline held a dominant market position, capturing more than a 73.2% share of the global Vitamin K2 market.
• North America dominates the Vitamin K2 market, holding a significant market share of 45.6%, translating to approximately USD 97.0 million.

How Growth is Impacting the Economy

The Vitamin K2 Market’s rapid growth. This expansion creates jobs in manufacturing, research, and distribution, particularly in regions like Asia Pacific, where rising disposable incomes fuel demand. The surge in health-conscious consumers drives investment in nutraceutical innovation, boosting economic activity in the supplement and functional food sectors. Small and medium enterprises benefit from e-commerce growth, enabling market entry and global reach.

Increased demand for plant-based and vegan K2 sources supports agricultural economies, especially in countries producing raw materials. Additionally, the market’s growth encourages healthcare cost savings by promoting preventive solutions for osteoporosis and cardiovascular diseases, reducing long-term medical expenditures. Urbanization and rising middle-class populations in emerging markets further amplify economic contributions, fostering sustainable growth and innovation in related industries like pharmaceuticals and cosmetics.

➤ Curious about the content? Explore a sample copy of this report – https://market.us/report/global-vitamin-k2-market/request-sample/

Strategies for Businesses

Businesses in the Vitamin K2 Market should capitalize on rising demand by investing in R&D for bioavailable MK-7 formulations and vegan-friendly K2 sources to cater to health-conscious and plant-based consumers. Leveraging e-commerce platforms can expand market reach, especially in Asia Pacific, where urbanization drives growth.

Partnerships with healthcare providers and fitness influencers can enhance brand visibility. Offering personalized nutrition solutions, such as tailored supplements, can attract niche markets. Additionally, businesses should explore pharmaceutical and cosmetic applications to diversify revenue streams. Adopting sustainable sourcing and transparent labeling will build consumer trust, ensuring long-term competitiveness in this rapidly expanding market.

Report Scope

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=150260

Key Market Segments

By Product

• In 2024, MK-7 led the global Vitamin K2 market with a 68.9% share, driven by its superior bioavailability, extended plasma half-life of up to 72 hours, and growing consumer preference for daily supplements. Derived primarily from Bacillus subtilis natto fermentation, MK-7 supports efficient calcium metabolism, benefiting bone and cardiovascular health. Its clean-label appeal and use in dietary supplements and functional foods, combined with regulatory approval and demand in North America, Europe, and Japan, ensure MK-7’s market dominance into 2025.

By Dosage Form

• Capsules and tablets commanded a 47.1% share of the global Vitamin K2 market in 2024, valued for their convenience, precise dosing, long shelf life, and widespread consumer acceptance. Popular in retail and e-commerce, these formats pair well with nutrients like Vitamin D3, calcium, and magnesium, appealing to health-conscious buyers. Cost-effective production and scalability further boost their use in pharmaceuticals and nutraceuticals.

By Source

• Natural Vitamin K2, primarily MK-7 from Bacillus subtilis natto fermentation, held a 67.4% market share in 2024. Its popularity stems from demand for clean-label, plant-based, and minimally processed supplements, seen as safer and more bioavailable for bone and heart health. Used widely in supplements, fortified foods, and beverages, natural K2 aligns with organic and vegetarian trends. In 2025, this segment is expected to grow as transparency and sustainability drive consumer choices.

By Indication

• Bone Health dominated the Vitamin K2 market in 2024 with a 51.3% share, fueled by rising awareness of age-related bone loss, particularly among postmenopausal women and seniors. MK-7’s role in activating osteocalcin for calcium binding enhances bone density and reduces fracture risk, often paired with calcium and Vitamin D3. Public health campaigns in Europe and North America, along with growing clinical evidence, support its use. The Bone Health segment is set to remain strong in 2025 as proactive aging solutions gain popularity.

By Application

• Health Supplements led the Vitamin K2 market in 2024, capturing a 77.7% share, driven by consumer focus on bone and cardiovascular wellness. Formulated into capsules, tablets, and softgels, often with calcium and Vitamin D3, K2 fits seamlessly into daily routines. Growth in retail across North America, Europe, and Asia, particularly for aging populations and women’s health, fuels this segment. Health Supplements will likely remain the market’s growth driver in 2025 as wellness trends expand.

By Distribution Channel

• Offline channels held a 73.2% share of the Vitamin K2 market in 2024, led by health supplement retailers, pharmacies, and supermarkets. In-person purchases remain popular for their accessibility, immediate availability, and expert advice from pharmacists or staff, especially among older consumers. In emerging markets, limited digital access strengthens traditional retail. Offline channels are expected to remain dominant in 2025, supported by in-store promotions and healthcare professional recommendations.

Regional Analysis

• North America leads the Vitamin K2 market, commanding a 45.6% share, equivalent to roughly USD 97.0 million. This prominence stems from growing consumer awareness of Vitamin K2’s benefits for bone and cardiovascular health. The thriving dietary supplements sector in the U.S. and Canada drives demand, further fueled by rising osteoporosis and heart disease cases, prompting healthcare professionals to recommend Vitamin K2 supplementation.
• The region’s dominance is reinforced by key industry players, innovative products, and effective marketing that emphasizes preventive healthcare. Advanced R&D in nutritional supplements results in improved formulations and diverse product offerings, appealing to varied consumer needs.
• A supportive regulatory framework, with clear guidelines from the FDA and Health Canada, fosters consumer confidence and sustains market growth. The aging population and a focus on preventive healthcare further boost demand. Collaborations between supplement manufacturers and healthcare providers to promote Vitamin K2 benefits continue to strengthen market expansion.

Recent Developments

1. NOW Foods

• NOW Foods has expanded its Vitamin K2 offerings with MK-7 (MenaQ7) and MK-4 blends, emphasizing heart and bone health. Their Vitamin K-2 100 mcg supplement is now non-GMO verified and tested for purity. Recent studies highlight its role in calcium metabolism, and NOW promotes synergistic formulas with D3 for enhanced absorption. The company also emphasizes sustainable sourcing.

2. Life Extension

• Life Extension introduced an advanced Super K2 with Advanced K2 Complex, combining MK-4, MK-7, and MK-9 for optimal bioavailability. Their research highlights K2’s role in vascular elasticity and osteoporosis prevention. The brand also released a Vitamin K2 + D3 + Calcium formulation. Life Extension continues to fund clinical trials on K2’s long-term cardiovascular benefits.

3. Pharmavite (Nature Made)

• Nature Made’s Vitamin K2 (as MK-7) 100 mcg softgels now feature USP-verified quality, ensuring potency and purity. Pharmavite highlights K2’s role in arterial health and bone density in recent consumer education campaigns. They also introduced a K2 + D3 gummy version for better compliance. Nature Made emphasizes third-party testing for heavy metals and contaminants.

4. Nestlé (Garden of Life)

• Garden of Life launched a whole-food Vitamin K2 (from natto) in their mykind Organics line, catering to clean-label consumers. Their Vitamin Code Raw K2 includes probiotics for gut health synergy. Nestlé’s research focuses on K2’s bioavailability from fermented sources, and they promote K2’s role in immune and metabolic health.

5. Bronson

• Bronson’s Vitamin K2 (MK-7) 300 mcg high-potency formula now includes organic coconut oil for better absorption. The brand emphasizes bone and cardiovascular support, with recent updates highlighting K2’s synergy with magnesium and D3. Bronson also introduced a K2 + D3 + Boron complex for enhanced bone metabolism.

Conclusion

The Vitamin K2 Market is a dynamic force in the nutraceutical sector. Its growth, driven by health-conscious consumers and innovative products, boosts economies through job creation and healthcare savings. Businesses can succeed by focusing on R&D, e-commerce, and sustainability. With promising opportunities in pharmaceuticals and personalized nutrition, the market’s future is vibrant, ensuring Vitamin K2 remains a key player in promoting global health and economic prosperity.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF